AU1176200A - Vaginally administrable progesterone-containing tablets and method for preparingsame - Google Patents

Vaginally administrable progesterone-containing tablets and method for preparingsame

Info

Publication number
AU1176200A
AU1176200A AU11762/00A AU1176200A AU1176200A AU 1176200 A AU1176200 A AU 1176200A AU 11762/00 A AU11762/00 A AU 11762/00A AU 1176200 A AU1176200 A AU 1176200A AU 1176200 A AU1176200 A AU 1176200A
Authority
AU
Australia
Prior art keywords
preparingsame
progesterone
containing tablets
vaginally administrable
vaginally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11762/00A
Other languages
English (en)
Inventor
Azariah Jossifoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Publication of AU1176200A publication Critical patent/AU1176200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU11762/00A 1998-11-18 1999-11-17 Vaginally administrable progesterone-containing tablets and method for preparingsame Abandoned AU1176200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL127129 1998-11-18
IL12712998A IL127129A (en) 1998-11-18 1998-11-18 Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
PCT/IL1999/000619 WO2000028970A1 (en) 1998-11-18 1999-11-17 Vaginally administrable progesterone-containing tablets and method for preparing same

Publications (1)

Publication Number Publication Date
AU1176200A true AU1176200A (en) 2000-06-05

Family

ID=11072154

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11762/00A Abandoned AU1176200A (en) 1998-11-18 1999-11-17 Vaginally administrable progesterone-containing tablets and method for preparingsame

Country Status (8)

Country Link
US (4) US7300664B1 (enExample)
EP (2) EP2386291A1 (enExample)
JP (2) JP4667601B2 (enExample)
AU (1) AU1176200A (enExample)
DK (1) DK1131052T3 (enExample)
ES (1) ES2390959T3 (enExample)
IL (1) IL127129A (enExample)
WO (1) WO2000028970A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
FR2821555B1 (fr) * 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
KR20050084445A (ko) * 2002-12-20 2005-08-26 다이노젠 파마세우티컬스, 인코포레이티드 α₂δ 서브유닛 칼슘 채널 모듈레이터를 이용한 무통증방광 질환의 치료방법
ES2275229T3 (es) * 2003-03-21 2007-06-01 Dynogen Pharmaceuticals, Inc. Metodos para el tratamiento de desordenes del tracto urinario iferior utilizando antimuscarinos y moduladores de la subunidad alfa-2-delta del canal de calcio.
DE10316583A1 (de) * 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CA2744906A1 (en) * 2007-11-29 2009-06-04 Gregg A. Jackson Progesterone-containing compositions and devices
US9107696B2 (en) 2008-08-06 2015-08-18 Emory University Method of embryo transfer that eliminates transferred air while hormonally inducing implantation and apparatus
WO2011073995A2 (en) 2009-12-14 2011-06-23 Lincoln Pharmaceuticals Limited Liquid vaginal spray of progesterone
FR2997627B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
CN114129530A (zh) * 2021-12-08 2022-03-04 南京康川济医药科技有限公司 一种黄体酮缓释组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121663A (en) 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
US4252787A (en) * 1976-12-27 1981-02-24 Cambridge Research And Development Group Anti-fertility composition and method
US4310510A (en) * 1976-12-27 1982-01-12 Sherman Kenneth N Self administrable anti-fertility composition
US4187286A (en) * 1979-01-02 1980-02-05 G&W Laboratories, Inc. Contraceptive suppository
US4322399A (en) * 1979-10-19 1982-03-30 Ortho Pharmaceutical Corporation Vaginal suppository
JPS58152809A (ja) * 1982-03-05 1983-09-10 Eisai Co Ltd 安定な発泡性「膣」坐剤
US4583211A (en) * 1982-06-15 1986-04-15 Tokyo Shibaura Denki Kabushiki Kaisha Frequency detecting circuit for digital information reproducing system
JPS6165822A (ja) * 1984-09-06 1986-04-04 Kao Corp 月経困難症治療用膣投与剤
US5116619A (en) * 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
US5084277A (en) * 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
CH689802A5 (de) * 1995-01-16 1999-11-30 Grapha Holding Ag Einrichtung zur Vereinzelung von stapelweise zugeführten flachen Gegenständen.
US5804277A (en) * 1995-11-30 1998-09-08 The United States Of America As Represented By The Secretary Of The Air Force Three-dimensional fiber weave with cubic symmetry and no zero valued shear moduli
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5837861A (en) * 1997-02-10 1998-11-17 Inspire Pharmaceuticals, Inc. Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
US5993856A (en) 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6306914B1 (en) * 1997-10-21 2001-10-23 Columbia Laboratories, Inc. Progestin therapy for maintaining amenorrhea
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
FR2772617B1 (fr) 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
US20070178139A1 (en) * 1998-11-18 2007-08-02 Yankov Vladimir I Vaginally administratable progesterone-containing tablets and method for preparing same
DE102012021570A1 (de) * 2012-11-02 2014-05-22 Merck Patent Gmbh Eu-aktivierte Leuchtstoffe

Also Published As

Publication number Publication date
WO2000028970A1 (en) 2000-05-25
US7300664B1 (en) 2007-11-27
US20060188571A1 (en) 2006-08-24
ES2390959T3 (es) 2012-11-20
JP2002529494A (ja) 2002-09-10
US7393543B2 (en) 2008-07-01
JP4667601B2 (ja) 2011-04-13
US7320800B2 (en) 2008-01-22
EP1131052B1 (en) 2012-07-11
DK1131052T3 (da) 2012-10-15
EP1131052A4 (en) 2009-04-01
IL127129A (en) 2004-06-01
US20050008694A1 (en) 2005-01-13
JP2011026335A (ja) 2011-02-10
US20050181045A1 (en) 2005-08-18
EP2386291A1 (en) 2011-11-16
IL127129A0 (en) 1999-09-22
EP1131052A1 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
AU2002300238A1 (en) Process for manufacturing bite-dispersion tablets
AU6106999A (en) Process
AU6352398A (en) Bioadhesive tablets
AU3890299A (en) Cryo-sedimentation process
AU3215500A (en) Compounds and methods
AU7989400A (en) Compounds and methods
AU5576699A (en) Rolling case
AU1766599A (en) Progesterone tablet and preparation method
AU1612200A (en) Apparatus and method for tablet fabrication
HUP0002248A3 (en) Tablets, and process for making tablets
EP1127060B8 (en) Hydroboronation process
AU2001279850A1 (en) Method and arrangement for studsystem
AU4942599A (en) Device and method for expansion forming
AU1176200A (en) Vaginally administrable progesterone-containing tablets and method for preparingsame
AU1538901A (en) Polymersation process
AUPP433398A0 (en) Compounds and processes
AU7566700A (en) Method and device for interlocking
AU5926800A (en) Semiconductor devices and process for manufacture
AU2744900A (en) Method and apparatus for manufacturing design
HUP0101059A3 (en) Detergent tablet and process for its manufacture
AU1291800A (en) Microparticles and process for making microparticles
AU3193200A (en) Tablets and process for producing the same
AU1734801A (en) Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyrancompound
AU2207001A (en) Novel compounds and process
AU5475499A (en) Video-to-film transfer process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase